AstraZeneca, the pharmaceutical titan known for its COVID-19 vaccine, embarks on a novel journey. They join forces with Absci, an American AI biologics company, aiming to transform cancer treatment with innovative antibodies.
Image: PBS
The partnership, unveiled in a Financial Times report on December 3, sees AstraZeneca committing a remarkable $247 million. This investment covers research, development, milestones, and an upfront fee for Absci.
Their joint mission? To develop a state-of-the-art generative AI model for new cancer antibody therapies. The exact cancer types targeted remain undisclosed.
Absci's website touts their AI prowess, capable of screening billions of cells weekly. They can swiftly turn antibodies into lab-validated candidates in just six weeks.
Image: GeekWire
Absci currently juggles 17 different projects. AstraZeneca's Senior VP, Puja Sapra, stresses AI's role in hastening and broadening biologics discovery. Absci’s CEO, Sean McClain, acknowledges the collaboration's significance in enhancing their AI work, as reported by Reuters.
While Cointelegraph's request for more details from Absci awaits a reply, the partnership is a testament to AI's growing footprint in healthcare. AI is already being leveraged elsewhere, such as in Hong Kong's Hospital Authority.
They employ an AI system to combat superbugs by optimizing antibiotic prescriptions.
In essence, AstraZeneca and Absci's alliance harnesses AI's potential in the ongoing battle against cancer. Their collaboration, backed by significant investment and advanced technology, holds promise for groundbreaking antibody treatments.
It's a clear indicator of AI's burgeoning role in reshaping healthcare research and treatment strategies.
Reuters reported on June 24, citing documents filed by U.S. prosecutors in the Northern Mariana Islands District Court, that the founder of WikiLeaks agreed to plead guilty to one count of conspiracy to obtain and disclose U.S. national defense information.
JinseFinanceKeiser warns of US banking crisis akin to Nakamoto's vision. Sternlicht predicts failures due to Fed policies. Keiser supports Kiyosaki's crash predictions, advocates Bitcoin, gold, and silver investments.
Xu LinArmstrong predicts XRP to lead the 2024 crypto bull run, citing its strong team, marketing, community, and technological advancements.
Alexwow. much money. how money so crypto. very currency.
ZoeyAmid SEC challenges and cryptocurrency disputes, Coinbase CEO Brian Armstrong calls for a stronger U.S. regulatory framework.
Hui XinAstraZeneca pioneers a healthcare revolution, unveiling Evinova to accelerate clinical trials and integrate digital solutions in a new era of medical advancements.
Hui Xin
BitcoinworldCrypto influencer Ben ‘BitBoy’ Armstrong has been released on bail following his arrest which involved a confrontation with his former business partner. The confrontation was partially live-streamed on X.
CatherineEvent host Wistaverse reveals that rally speakers will appear as digital personas within the event or contribute via pre-recorded videos displayed within the digital arena.
BrianHe suggests that crypto's success has been largely caused by almost nonexistent interest rates, which pushed people toward speculation instead of 'real finance'.
Others